Daxor Corporation DXR

DXR Company Overview

Daxor Corporation (NYSE American: DXR) is a U.S.-based medical technology and healthcare company focused on blood volume measurement and diagnostic analytics. The company operates primarily in the healthcare technology and medical diagnostics industries, with its core business centered on the development, commercialization, and support of the BVA-100 Blood Volume Analyzer, a diagnostic system designed to measure a patient’s blood volume and optimize fluid management in clinical settings. The company’s technology is used by hospitals, physicians, and healthcare systems treating conditions such as heart failure, critical illness, surgery recovery, and complex fluid-balance disorders.

Daxor traces its origins to a broader biotechnology and diagnostics business before evolving into a specialized medical technology company focused on blood-volume diagnostics and personalized fluid management. Over time, the company concentrated its strategy around proprietary blood-volume analysis technology and related clinical applications. Its positioning is based on offering quantitative blood-volume assessment intended to improve treatment precision compared with traditional estimation methods commonly used in hospital care.